DK0402950T3 - Behandling af postmenopausale ulemper - Google Patents

Behandling af postmenopausale ulemper

Info

Publication number: DK0402950T3
Authority: DK; Denmark
Prior art keywords: daily; separate; dosage units; sequential; compound
Prior art date: 1989-06-15

Application number

DK90111365.4T

Other languages

English (en)

Inventor

Erkki Hirvonen

Ariel Gordin

Original Assignee

Orion Yhtym Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-06-15

Filing date

1990-06-15

Publication date

1993-10-25

1990-06-15 Application filed by Orion Yhtym Oy filed Critical Orion Yhtym Oy

1993-10-25 Application granted granted Critical

1993-10-25 Publication of DK0402950T3 publication Critical patent/DK0402950T3/da

Links

150000001875 compounds Chemical class 0.000 abstract 3
230000037406 food intake Effects 0.000 abstract 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
208000035475 disorder Diseases 0.000 abstract 2
230000001076 estrogenic effect Effects 0.000 abstract 2
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Natural products C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 1
201000006828 endometrial hyperplasia Diseases 0.000 abstract 1
239000000262 estrogen Substances 0.000 abstract 1
229940011871 estrogen Drugs 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
230000001072 progestational effect Effects 0.000 abstract 1
229960003387 progesterone Drugs 0.000 abstract 1
239000000186 progesterone Substances 0.000 abstract 1
-1 progesterone compound Chemical class 0.000 abstract 1
239000000583 progesterone congener Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Medicines Containing Plant Substances (AREA)

DK90111365.4T 1989-06-15 1990-06-15 Behandling af postmenopausale ulemper DK0402950T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/366,424 US5043331A (en)	1989-06-15	1989-06-15	Treatment of postmenopausal disorders

Publications (1)

Publication Number	Publication Date
DK0402950T3 true DK0402950T3 (da)	1993-10-25

Family

ID=23442937

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90111365.4T DK0402950T3 (da)	1989-06-15	1990-06-15	Behandling af postmenopausale ulemper

Country Status (10)

Country	Link
US (1)	US5043331A (da)
EP (1)	EP0402950B1 (da)
JP (1)	JPH0331213A (da)
AT (1)	ATE93728T1 (da)
AU (1)	AU635270B2 (da)
CA (1)	CA2018818C (da)
DE (2)	DE69003015D1 (da)
DK (1)	DK0402950T3 (da)
IE (1)	IE65864B1 (da)
NZ (1)	NZ234051A (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU222501B1 (hu) *	1991-06-28	2003-07-28	Endorecherche Inc.	MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
ZA924811B (en) *	1991-06-28	1993-12-29	Endorecherche Inc	Controlled release systems and low dose androgens
JP2722025B2 (ja) *	1991-07-19	1998-03-04	日本鋼管工事株式会社	光ファイバ融着部測定システム
DE4405590C1 (de) *	1994-02-22	1995-07-20	Hesch Rolf Dieter Prof Dr Med	Mittel zur postmenopausalen Hormonbehandlung
DE19815060A1 (de) *	1998-04-03	1999-10-14	Jenapharm Gmbh	Pharmazeutische Präparate zur Therapie von Nebenwirkungen während und/oder nach einer GnRHa-Therapie
US6165504A (en) *	1998-09-23	2000-12-26	Barr Laboratories, Inc.	Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
US7989436B2 (en)	2003-07-23	2011-08-02	Duramed Pharmaceuticals, Inc.	Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) *	2000-03-10	2008-12-02	Duramed Pharmaceuticals, Inc.	Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en)	2000-03-10	2005-02-15	Endeavor Pharmaceuticals	Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6660726B2 (en)	2000-03-10	2003-12-09	Endeavor Pharmaceuticals	Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US20020151530A1 (en)	2000-12-22	2002-10-17	Leonard Thomas W.	Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
EP1390038A2 (en)	2001-05-16	2004-02-25	Endeavor Pharmaceuticals	Treatment of conditions relating to hormone deficiencies by administration of progestins
PT1390040E (pt)	2001-05-18	2007-04-30	Pantarhei Bioscience Bv	Composição farmacêutica para ser utilizado na terapia hormonal de substituição.
ES2337129T3 (es)	2001-05-23	2010-04-21	Pantarhei Bioscience B.V.	Sistema de administracion de medicamento comprendiendo un estrogeno tetrahidroxilado para el uso en la anticoncepcion hormonal.
EP1390042B1 (en)	2001-05-23	2007-11-28	Pantarhei Bioscience B.V.	Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
US8026228B2 (en)	2001-11-15	2011-09-27	Pantarhei Bioscience B.V.	Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
CN100581550C (zh) *	2001-12-05	2010-01-20	杜拉美德药物有限公司	预防怀孕和减少经期前症状的口服避孕药
EP1340503A1 (en) *	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1494679A4 (en) *	2002-04-03	2009-10-28	Barr Lab Inc	STEP-BY-STEP ESTROGENTHERAPY
CN100352445C (zh)	2002-06-11	2007-12-05	潘塔希生物科学股份有限公司	一种皮肤护理组合物及其用途
PT1511496E (pt)	2002-06-11	2007-01-31	Pantarhei Bioscience Bv	Método para tratamento ou prevenção de doenças mediadas pelo sistema imunitário e formulação farmacológica para utilização nas mesmas
SI1526856T1 (sl)	2002-07-12	2008-04-30	Pantarhei Bioscience Bv	Farmacevtski sestavek, ki obsega estetrolne derivate za uporabo pri zdravljenju raka
SI1556058T1 (sl)	2002-10-23	2008-02-29	Pantarhei Bioscience Bv	Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
US6992075B2 (en) *	2003-04-04	2006-01-31	Barr Laboratories, Inc.	C(14) estrogenic compounds
MXPA05010871A (es) *	2003-04-11	2005-11-25	Barr Lab Inc	Metodos para administrar estrogenos y progestinas.
EP1624848A4 (en) *	2003-05-02	2009-02-25	Duramed Pharmaceuticals Inc	METHOD FOR HORMONY TREATMENT WITH CONTRAZEPTVA SCHEMATES WITH EXTENDED CYCLE
CN101001631B (zh) *	2003-07-16	2014-08-06	特卫华妇女健康有限公司	利用连续给予雌激素的避孕方案的激素治疗方法
WO2005032558A1 (en) *	2003-10-01	2005-04-14	Janssen Pharmaceutica N.V.	Extended triphasic contraceptive regimens
US20070111975A1 (en) *	2004-10-07	2007-05-17	Duramed Pharmaceuticals, Inc.	Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
ATE473746T1 (de)	2007-01-08	2010-07-15	Pantarhei Bioscience Bv	Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US8633178B2 (en)	2011-11-23	2014-01-21	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20190022107A1 (en) *	2017-06-08	2019-01-24	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
EP3145489A1 (en)	2014-05-22	2017-03-29	TherapeuticsMD, Inc.	Natural combination hormone replacement formulations and therapies
US11633405B2 (en)	2020-02-07	2023-04-25	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4425339A (en) *	1981-04-09	1984-01-10	Syntex (U.S.A.) Inc.	Treatment of menopausal symptoms
US4826831A (en) *	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
IE61236B1 (en) *	1986-07-15	1994-10-19	American Home Prod	Combination dosage form for pre-menopausal women

1989
- 1989-06-15 US US07/366,424 patent/US5043331A/en not_active Expired - Lifetime
1990
- 1990-05-23 AU AU55876/90A patent/AU635270B2/en not_active Ceased
- 1990-06-12 CA CA002018818A patent/CA2018818C/en not_active Expired - Fee Related
- 1990-06-13 NZ NZ234051A patent/NZ234051A/xx unknown
- 1990-06-14 JP JP2156610A patent/JPH0331213A/ja active Pending
- 1990-06-15 AT AT90111365T patent/ATE93728T1/de not_active IP Right Cessation
- 1990-06-15 IE IE216490A patent/IE65864B1/en not_active IP Right Cessation
- 1990-06-15 DK DK90111365.4T patent/DK0402950T3/da active
- 1990-06-15 EP EP90111365A patent/EP0402950B1/en not_active Expired - Lifetime
- 1990-06-15 DE DE90111365A patent/DE69003015D1/de not_active Expired - Fee Related
- 1990-06-15 DE DE69003015T patent/DE69003015T4/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NZ234051A (en)	1991-09-25
US5043331A (en)	1991-08-27
EP0402950A2 (en)	1990-12-19
IE65864B1 (en)	1995-11-29
JPH0331213A (ja)	1991-02-12
CA2018818A1 (en)	1990-12-15
DE69003015T2 (de)	1993-12-16
AU5587690A (en)	1990-12-20
CA2018818C (en)	2001-01-16
EP0402950B1 (en)	1993-09-01
DE69003015T4 (de)	1994-05-26
IE902164A1 (en)	1991-01-02
IE902164L (en)	1990-12-15
DE69003015D1 (de)	1993-10-07
AU635270B2 (en)	1993-03-18
EP0402950A3 (en)	1991-02-06
ATE93728T1 (de)	1993-09-15

Publication	Publication Date	Title
DK0402950T3 (da)	1993-10-25	Behandling af postmenopausale ulemper
NO914970D0 (no)	1991-12-16	Prostagen-bare kontraseptiv
MD1920F2 (ro)	2002-05-31	Compoziţie şi metodă de profilaxie sau frânare a debutului bolii Alzheimer
NZ219776A (en)	1990-03-27	11-substituted steroid 17, 2'-furan derivatives and pharmaceutical compositions
TR199802705T2 (xx)	1999-03-22	Progestojen-anti-progestojen k�r�
FI970526A7 (fi)	1997-02-07	Estra-1,3,5(10)-trieenijohdannaiset, niiden valmistusmenetelmät sekä n äitä yhdisteitä sisältävät farmaseuttiset koostumukset
ATE155039T1 (de)	1997-07-15	Mit zucker überzogene pharmazeutische dosierungseinheit
BR0114665A (pt)	2004-01-13	Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio
FI971742A7 (fi)	1997-04-23	Kompetitiivisia progesteroniantagonisteja tarpeen sanelemaan raskauden ehkäisyyn naisilla
EP0438147A3 (en)	1991-10-16	Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
MX9702253A (es)	1997-06-28	Nuevos estrenos para inducir efectos hipotalamicos
ITMI913510A1 (it)	1993-07-01	Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
CA2248841A1 (en)	1997-09-18	Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
IL113816A0 (en)	1995-08-31	Pharmaceutical compositions containing desogestrel their preparation and use
FR2685204B1 (fr)	1995-06-16	Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
ES8703872A1 (es)	1987-03-01	Procedimiento para preparar derivados de isoquinolina.
FR2713088B1 (fr)	1996-03-22	Utilisation de la vitamine B1 et ses dérivés pour la préparation d'un médicament destiné au traitement des affections dont les symptômes sont attribués aux désordres d'origine vasculaire.
FR2602680B1 (fr)	1993-04-16	Compositions pharmaceutiques pour l'administration par voie nasale
RU96124465A (ru)	1999-02-20	Способ лечения стойких дезадаптационных психовегетативных расстройств
IL137496A0 (en)	2001-07-24	Dosage form and pharmaceutical kit for increasing the oral availablity of pharmaceutical agents